Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2017

  • ID: 4315808
  • Report
  • 56 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Bioptigen, Inc.
  • Cleveland Clinic Hospital
  • Duke University
  • OptoQuest
  • Optovue Inc
  • University of Rochester
  • MORE
Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2017

Summary

The analyst's Medical Devices sector report, “Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2017" provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Optical Coherence Tomography (OCT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bioptigen, Inc.
  • Cleveland Clinic Hospital
  • Duke University
  • OptoQuest
  • Optovue Inc
  • University of Rochester
  • MORE
1 Table of Contents
2 Introduction
2.1 Optical Coherence Tomography (OCT) Overview
3 Products under Development
3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory
3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies
4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
5 Optical Coherence Tomography (OCT) Companies and Product Overview
5.1 Bioptigen, Inc. Company Overview
5.1.1 Bioptigen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Canon U.S.A. Inc Company Overview
5.2.1 Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cleveland Clinic Hospital Company Overview
5.3.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.4 Compact Imaging Inc. Company Overview
5.4.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview
5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
5.6 Duke University Company Overview
5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.7 George Washington University Company Overview
5.7.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Heidelberg Engineering GmbH Company Overview
5.8.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.9 Leica Microsystems GmbH Company Overview
5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.10 Moorfields Eye Hospital NHS Foundation Trust Company Overview
5.10.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
5.11 OptoQuest Company Overview
5.11.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview
5.12 Optos Plc Company Overview
5.12.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Optovue Inc Company Overview
5.13.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Sinoora Inc. Company Overview
5.14.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.15 University of California Berkeley Company Overview
5.15.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
5.16 University of Rochester Company Overview
5.16.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.17 Volcano Corp Company Overview
5.17.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview
6 Optical Coherence Tomography (OCT)- Recent Developments
6.1 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec
6.2 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17
6.3 May 08, 2017: ZEISS Appoints New Fellow
6.4 Apr 28, 2017: ZEISS integrates new Barrett Suite into IOLMaster SWEPT Source Biometry for better refractive outcomes and fewer refractive surprises
6.5 Apr 25, 2017: Optovue First to Release High Density OCT Angiography for Ophthalmology
6.6 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million
6.7 Mar 19, 2017: Wally Kojima, O.D. and Associates Detects Glaucoma Earlier with FDA-Approved Topcon 3D OCT-1 Maestro
6.8 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17
6.9 Jan 31, 2017: Oclaro Announces Second Quarter Fiscal Year 2017 Financial Results
6.10 Jan 18, 2017: Oclaro Announces Preliminary Second Quarter Fiscal 2017 Financial Results
6.11 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend
6.12 Nov 01, 2016: Oclaro Announces First Quarter Fiscal Year 2017 Financial Results
6.13 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer
6.14 Aug 29, 2016: Oclaro Appoints Global Human Resources Veteran to Board of Directors
6.15 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery
6.16 Aug 08, 2016: Optovue Announces New Distribution Agreement With ROCOL in Colombia
6.17 Aug 02, 2016: Oclaro Announces Fourth Quarter and Fiscal Year 2016 Financial Results
6.18 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization
6.19 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Table 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
Table 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
Table 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
Table 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
Table 6: Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
Table 7: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Table 8: Bioptigen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Microscope Integrated Intraoperative OCT - Product Status
Table 10: Microscope Integrated Intraoperative OCT - Product Description
Table 11: Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: SPOCT HR - Product Status
Table 13: SPOCT HR - Product Description
Table 14: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Interoperative OCT System - Product Status
Table 16: Interoperative OCT System - Product Description
Table 17: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: MRO Optical Imaging Sensor - Product Status
Table 19: MRO Optical Imaging Sensor - Product Description
Table 20: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 21: MD-SD-OCT Instrument - Product Status
Table 22: MD-SD-OCT Instrument - Product Description
Table 23: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 24: HH - SDOCT - Product Status
Table 25: HH - SDOCT - Product Description
Table 26: Microscope Integrated OCT System - Product Status
Table 27: Microscope Integrated OCT System - Product Description
Table 28: Duke University - Ongoing Clinical Trials Overview
Table 29: Microscope Integrated OCT System - Intraoperative OCT Guidance of Intraocular Surgery
Table 30: George Washington University Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Amplified Bimorph Scanning Mirror System - Product Status
Table 32: Amplified Bimorph Scanning Mirror System - Product Description
Table 33: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Cataract And Refractive Imaging Platform - Product Status
Table 35: Cataract And Refractive Imaging Platform - Product Description
Table 36: SPECTRALIS OCT2 Module - OCT Angiography - Product Status
Table 37: SPECTRALIS OCT2 Module - OCT Angiography - Product Description
Table 38: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 39: DI-SDOCT Imaging System - Product Status
Table 40: DI-SDOCT Imaging System - Product Description
Table 41: SDOCT Scanner - Product Status
Table 42: SDOCT Scanner - Product Description
Table 43: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Binocular Optical Coherence Tomography - Product Status
Table 45: Binocular Optical Coherence Tomography - Product Description
Table 46: OptoQuest Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Vectralis - Product Status
Table 48: Vectralis - Product Description
Table 49: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Falcon I - Product Status
Table 51: Falcon I - Product Description
Table 52: Falcon II - Product Status
Table 53: Falcon II - Product Description
Table 54: Lotte - Product Status
Table 55: Lotte - Product Description
Table 56: Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: AngioAnalytics - Product Status
Table 58: AngioAnalytics - Product Description
Table 59: Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 60: On-chip Spectral Coherence Tomography System - Product Status
Table 61: On-chip Spectral Coherence Tomography System - Product Description
Table 62: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Directional Optical Coherence Tomography Device - Product Status
Table 64: Directional Optical Coherence Tomography Device - Product Description
Table 65: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Scanning Optical System - Product Status
Table 67: Scanning Optical System - Product Description
Table 68: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Swept Laser Integrated OEM OCT Ophthalmic OCT System - Product Status
Table 70: Swept Laser Integrated OEM OCT Ophthalmic OCT System - Product Description
Table 71: Glossary

List of Figures
Figure 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
Figure 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory
Figure 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
Figure 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
Figure 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bioptigen, Inc.
  • Canon U.S.A. Inc
  • Cleveland Clinic Hospital
  • Compact Imaging Inc.
  • Costruzioni Strumenti Oftalmici Cso Srl
  • Duke University
  • George Washington University
  • Heidelberg Engineering GmbH
  • Leica Microsystems GmbH
  • Moorfields Eye Hospital NHS Foundation Trust
  • OptoQuest
  • Optos Plc
  • Optovue Inc
  • Sinoora Inc.
  • University of California Berkeley
  • University of Rochester
  • Volcano Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll